Holen Sie sich die Stockscreener-App
2.00
4.19%
0.09
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLS?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.91
Offen:
$1.99
24-Stunden-Volumen:
4.49M
Relative Volume:
2.04
Marktkapitalisierung:
$210.07M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-37.34M
KGV:
-1.4706
EPS:
-1.36
Netto-Cashflow:
$-36.91M
1W Leistung:
+5.29%
1M Leistung:
+7.57%
6M Leistung:
+76.11%
1J Leistung:
+60.48%
1-Tages-Spanne:
$1.94
$2.15
1-Wochen-Bereich:
$1.81
$2.15
52-Wochen-Spanne:
$0.772
$2.2691
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
Firmenname
Sellas Life Sciences Group Inc
Sektor
Branche
Telefon
(646) 200-5278
Adresse
7 TIMES SQUARE, NEW YORK, NY
Vergleichen Sie SLS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLS
Sellas Life Sciences Group Inc
|
1.995 | 238.72M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.20 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.85 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.46 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
807.98 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
330.21 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-07-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-11-01 | Eingeleitet | Oppenheimer | Outperform |
| 2018-04-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Hochstufung | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc Aktie (SLS) Neueste Nachrichten
What technical models suggest about SELLAS Life Sciences Group Inc.’s comebackMarket Activity Report & Real-Time Market Trend Scan - newser.com
SELLAS to present CDK9 inhibitor data for T-cell leukemia at ESMO - Investing.com Australia
Quantitative breakdown of SELLAS Life Sciences Group Inc. recent moveGlobal Markets & Daily Chart Pattern Signal Reports - newser.com
How institutional ownership impacts SELLAS Life Sciences Group Inc. stockPortfolio Update Summary & Target Return Focused Stock Picks - newser.com
SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025 - GlobeNewswire
7.9w survival — SELLAS' SLS009 prolongs life in T-PLL vs 4.4w venetoclax; poster at ESMO Oct 18 - Stock Titan
Smart tools for monitoring SELLAS Life Sciences Group Inc.’s price actionInsider Selling & Fast Gain Swing Alerts - newser.com
Published on: 2025-10-13 00:27:53 - newser.com
How SELLAS Life Sciences Group Inc. stock valuations compare to rivals2025 Major Catalysts & Real-Time Volume Spike Alerts - newser.com
What data driven models say about SELLAS Life Sciences Group Inc.’s futureMarket Trend Review & Weekly Momentum Stock Picks - newser.com
Using data models to predict SELLAS Life Sciences Group Inc. stock movementJuly 2025 Decliners & Precise Entry and Exit Recommendations - newser.com
What analyst consensus says on SELLAS Life Sciences Group Inc. stock2025 Momentum Check & Weekly Sector Rotation Insights - newser.com
How to integrate SELLAS Life Sciences Group Inc. into portfolio analysis toolsPortfolio Performance Report & High Return Trade Guides - newser.com
Using R and stats models for SELLAS Life Sciences Group Inc. forecastingExit Point & Expert Approved Momentum Ideas - newser.com
Published on: 2025-10-09 03:27:21 - newser.com
Published on: 2025-10-09 03:07:14 - newser.com
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Sees Significant Decrease in Short Interest - Defense World
Multi factor analysis applied to SELLAS Life Sciences Group Inc.July 2025 Momentum & Stepwise Entry/Exit Trade Alerts - newser.com
Using Python tools to backtest SELLAS Life Sciences Group Inc. strategies2025 Dividend Review & Free Accurate Trade Setup Notifications - newser.com
Can SELLAS Life Sciences Group Inc. (RXK3) stock double in coming years2025 Short Interest & Stock Market Timing Techniques - newser.com
Published on: 2025-10-06 05:59:31 - newser.com
SELLAS Extends Times Square Sublease Agreement - TipRanks
Why SELLAS Life Sciences Group Inc. (RXK3) stock benefits from AI revolutionEarnings Risk Summary & Community Consensus Picks - newser.com
Published on: 2025-10-03 03:10:59 - newser.com
Chart based analysis of SELLAS Life Sciences Group Inc. trendsJuly 2025 Patterns & Weekly Top Gainers Trade List - newser.com
Is SELLAS Life Sciences Group Inc. stock bottoming out2025 Buyback Activity & Daily Profit Focused Screening - newser.com
Published on: 2025-10-02 22:11:46 - newser.com
Will SELLAS Life Sciences Group Inc. (RXK3) stock test record highs in 20252025 Volume Leaders & High Conviction Investment Ideas - newser.com
SELLAS Life Sciences Group to Host Virtual R&D Day on October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 Program Update - Sahm
SELLAS Life Sciences to host virtual R&D day on AML treatments - Investing.com Nigeria
How Product Roadmap Could Affect Music Broadcast Limiteds Future ValueResistance Zone Identification & Free Stock Education Platform for New Investors - earlytimes.in
SELLAS Life Sciences to host virtual R&D day on AML treatments By Investing.com - Investing.com South Africa
What drives SELLAS Life Sciences Group Inc RXK3 stock priceHigh Beta Stocks & Fast Growing Investment Plans - earlytimes.in
SELLAS Life Sciences Group to Host Virtual R&D Day on - GlobeNewswire
Major AML Treatment Updates: SELLAS Life Sciences to Reveal Phase 3 REGAL Results & New Drug Progress - Stock Titan
Published on: 2025-09-30 01:16:34 - newser.com
What high frequency data says about SELLAS Life Sciences Group Inc.Market Activity Recap & Weekly Momentum Picks - newser.com
Published on: 2025-09-29 11:38:19 - newser.com
Published on: 2025-09-29 09:42:54 - newser.com
SELLAS Life Sciences Group Inc RXK3 Stock Analysis and ForecastMomentum Stock Picks & Budget Friendly Growth - earlytimes.in
What drives Deere Company stock priceSector Performance Drivers & Boost Wealth With Growth - earlytimes.in
Finanzdaten der Sellas Life Sciences Group Inc-Aktie (SLS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sellas Life Sciences Group Inc-Aktie (SLS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Wasman Jane | Director |
May 30 '25 |
Buy |
1.69 |
20,000 |
33,800 |
30,400 |
| Kalin Katherine Bach | Director |
May 22 '25 |
Buy |
1.80 |
20,000 |
36,000 |
41,000 |
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):